TylerLoveall

Associate

Detroit + 1.313.230.7946

Conectar

Compartilhe

Tyler Loveall represents hospitals, health systems, digital health care companies, and other health care entities on regulatory and transactional matters.

Tyler counsels clients on digital health and telehealth, the international practice of medicine, clinical research, corporate structuring, pharmacy practice, and many other health care areas. He also provides advice on complex contracting issues.

Tyler maintains an active pro bono practice, representing veterans before the VA (U.S. Department of Veterans Affairs) and victims of sexual assault in connection with requests for restitution and counseling nonprofit organizations.

Prior to attending law school, Tyler served as a secondary English education volunteer for the Peace Corps in Comoros in East Africa.

Experiência

  • Direct lender provides $35 million senior secured credit facility to large private equity-backed leading provider of lease accounting and lease management software solutionsJones Day advised a direct lender, as administrative agent, in connection with a $35 million senior secured credit facility provided to a large private equity sponsored company that is the leading provider of lease accounting and lease management software solutions in North America.
  • NOVA Infrastructure Management and its affiliated funds obtain new revolving subscription facility of up to $150 millionJones Day represented NOVA Infrastructure Management, LLC and its funds, NOVA Infrastructure Fund II, L.P. and NOVA Infrastructure Fund II (Cayman), L.P. in connection with a new subscription line facility of up to $150 million with Webster Bank, N.A., as the sole lender.
  • ETS acquires Mastery Transcript Consortium (MTC)Jones Day advised Educational Testing Service (ETS) in its acquisition of Mastery Transcript Consortium (MTC), a national non-profit organization that helps make competency-based education available to all learners.
  • Major U.S. software company conducts enhanced end user due diligence requirementsJones Day assisted a major U.S. software company with enhanced end user due diligence requirements in compliance with a procedure from the Bureau of Industry and Security (BIS).
  • NOVA Infrastructure Management, LLC and affiliated funds obtain new $25 million subscription facilityJones Day represented NOVA Infrastructure Management, LLC and its fund NOVA Infrastructure Fund I, L.P. (“NOVA I”) in the refinancing of NOVA I's existing subscription line facility.
  • Radial Equity acquires Moss Motors and Rimmer BrosJones Day advised Radial Equity Partners in the acquisition and financing of Moss Motors, a U.S.-headquartered aftermarket supplier of parts for British cars, and Rimmer Bros, a UK-based supplier of replacement parts for UK marque vehicles.
  • J.F. Lehman & Company acquires Mission MicrowaveJones Day advised J.F. Lehman & Company in the acquisition and financing of all of the outstanding membership interests of Mission Microwave Technologies, LLC, a revolutionary designer of radio frequency and microwave electronics supporting ground-based, airborne and space-based applications.
  • Diebold Nixdorf obtains $200 million super-priority senior secured revolving credit facilityJones Day represented Diebold Nixdorf, Incorporated, a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, and certain of its domestic subsidiaries in obtaining a $200 million super-priority senior secured revolving credit facility.
  • MEDHOST sells company to N. Harris Computer CorporationJones Day advised MEDHOST, Inc., a leading electronic health record solution provider, in its sale of the company to N. Harris Computer Corporation, a wholly-owned subsidiary of Constellation Software, Inc.
    •

    May 2024 Commentary

    NIH Seeks Comments on Patient Access Plan Requirements in Patent License Agreements

    May 2024 Commentary

    Canadian Drug Importation May Undermine Intellectual Property Protection

    March 2024 Alert

    Federal Agencies Launch Joint Inquiry Into Private Investment in Health Care

    Antes de enviar, por favor observe que:

    a Informação contida neste website (www.jonesday.com) destina-se a uso geral e não pode ser considerada como assessoria jurídica. O envio deste e-mail não tem por finalidade criar e seu recebimento não constitui uma relação cliente-advogado. Quaisquer conteúdos enviados para profissionais do Jones Day não são considerados confidenciais ou privilegiados a menos que sejamos seu representante legal. Ao enviar esta mensagem, você confirma que leu e concorda com este aviso.